Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 ...

As competitive as the obesity drug market has become, Novo Nordisk's decision to slash the prices of its GLP-1 agonist drugs ...

Discover the revolutionary needle-free weight-loss pill orforglipron, often referred to as 'Ozempic 2.0'. Learn how it ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

Next-generation pills and monthly injectables promise more choice, fewer side effects and broader health benefits.

A pharmacist has shared that taking a simple pill is recommended during December and the winter months. It can boost your ...

The manufacturers of Ozempic and Mounjaro are creating oral weight loss medications that could change treatment methods. These daily pills, pending FDA approval, reportedly show significant results in ...

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

Drugs that mimic the hormone GLP 1 have transformed obesity and diabetes care in recent years. Brands such as Ozempic and ...